Thursday, 26 March 2015 00:00 Written by Caitlyn Fitzpatrick
Although there is not an existing blood test that can identify early-stage osteoarthritis (eOA), a new biomarker finding documented in Nature Scientific Reports could be the first step in developing one.Naila Rabbani, PhD, and colleagues at Warwick Medical School created an algorithm that could lead to an osteoarthritis diagnosis before any physical symptoms occur with just a single test. They based their analysis in part on previous research that showed people with early-stage rheumatoid arthritis (eRA) may have citrullinated proteins (CPs) in their blood.
Published in Arthritis News
Tuesday, 24 March 2015 00:00 Written by DAILY MAIL REPORTER
Having a waltz around the room or enjoying a yoga class can work wonders for millions of people suffering from arthritis, say researchers.A study found hospital-based exercise programs such as Pilates, yoga or dance fitness can relieve the pain of the disease.American scientists studied at the effectiveness of exercise programmes run by the Hospital for Special Surgery in New York City. They found the weekly programmes significantly improved enjoyment of life and balance, and decreased pain and the severity and frequency of falls.
Published in Alternative Medicine
Thursday, 19 March 2015 00:00 Written by Tommy
Scientists have succeeded in producing cartilage formed from embryonic stem cells that could in future be used to treat the painful joint condition osteoarthritis. In research funded by Arthritis Research UK, Professor Sue Kimber and her team in the Faculty of Life Sciences at The University of Manchester has developed a protocol under strict laboratory conditions to grow and transform embryonic stem cells into cartilage cells (also known as chondrocytes).
Thursday, 12 March 2015 00:00 Written by setpointmedical.com
SetPoint Medical is dedicated to treating patients with debilitating inflammatory diseases, such as Crohn's Disease and rheumatoid arthritis, using proprietary implantable neuromodulation devices. The scientific platform is based on the Inflammatory Reflex—the natural mechanism by which the central nervous system regulates the immune system. This mechanism was discovered by SetPoint co-founder Kevin Tracey and published in Nature in May 2000. Since then, the Inflammatory Reflex has been characterized in more than 100 peer reviewed papers in leading scientific journals. Anti-inflammatory potency comparable to leading drugs has been demonstrated in multiple animal models. The company is currently conducting human trials in rheumatoid arthritis at four European centers.